A framework for an evidence-based gene list relevant to autism spectrum disorder
Citation:
Schaaf, C.P. and Betancur, C. and Yuen, R.K.C. and Parr, J.R. and Skuse, D.H. and Gallagher, L. and Bernier, R.A. and Buchanan, J.A. and Buxbaum, J.D. and Chen, C.-A. and Dies, K.A. and Elsabbagh, M. and Firth, H.V. and Frazier, T. and Hoang, N. and Howe, J. and Marshall, C.R. and Michaud, J.L. and Rennie, O. and Szatmari, P. and Chung, W.K. and Bolton, P.F. and Cook, E.H. and Scherer, S.W. and Vorstman, J.A.S., A framework for an evidence-based gene list relevant to autism spectrum disorder, Nature Reviews Genetics, 2020, 21, 6, 367-376Download Item:
Abstract:
Autism spectrum disorder (ASD) is often grouped with other brain-related phenotypes into a broader category of neurodevelopmental disorders (NDDs). In clinical practice, providers need to decide which genes to test in individuals with ASD phenotypes, which requires an understanding of the level of evidence for individual NDD genes that supports an association with ASD. Consensus is currently lacking about which NDD genes have sufficient evidence to support a relationship to ASD. Estimates of the number of genes relevant to ASD differ greatly among research groups and clinical sequencing panels, varying from a few to several hundred. This Roadmap discusses important considerations necessary to provide an evidence-based framework for the curation of NDD genes based on the level of information supporting a clinically relevant relationship between a given gene and ASD.
Author's Homepage:
http://people.tcd.ie/lgallagh
Author: Gallagher, Louise
Type of material:
Journal ArticleCollections
Series/Report no:
Nature Reviews Genetics;21;
6;
Availability:
Full text availableDOI:
http://dx.doi.org/10.1038/s41576-020-0231-2Metadata
Show full item recordThe following license files are associated with this item: